Sign In
Buy FLGT
$18.14
-0.560 (-2.99%)
At Close: Jun 03, 2026
Fulgent Genetics, Inc. (FLGT) CEO Ming Hsieh on Q3 2020 Results - Quick Version Earnings Call Transcript
06:55pm, Monday, 09'th Nov 2020
Fulgent Genetics, Inc. (FLGT) CEO Ming Hsieh on Q3 2020 Results - Quick Version Earnings Call Transcript
Buy One Fulgent, Get COVID-19 Testing Business Free
09:58am, Wednesday, 04'th Nov 2020
Fulgent has a successful genetic testing business growing at 50% that should benefit from the reduced cost of sequencing. However, more recently, Fulgent's COVID-19 business has seen greater success a
Wall Street Breakfast: What Moved Markets
02:01pm, Saturday, 29'th Aug 2020
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify.
Fulgent's Epic Ramp In Testing Is One For The Ages
11:37am, Thursday, 20'th Aug 2020
It's only a relatively small player in the rapidly expanding field of genetic testing, but this is changing in front of our eyes.
Fulgent Genetics Announces Expansion into Houston, TX
11:00am, Monday, 17'th Aug 2020
CLIA-Certified Laboratory will Increase Testing Capacity Raising FY20 Revenue Guidance to $135 Million from $120 MillionTEMPLE CITY, Calif., Aug. 17, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (
The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO
12:00am, Thursday, 06'th Aug 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 5)
ABIOMED, Inc. (NASDAQ: ABMD)
Aerpio Pharmaceuticals Inc (NASDAQ: ARPO) (announced a U.S. government grant for a...
A Quick Analysis On Fulgent Genetics' (NASDAQ:FLGT) CEO Compensation
11:26am, Wednesday, 05'th Aug 2020
This article will reflect on the compensation paid to Ming Hsieh who has served as CEO of Fulgent Genetics, Inc...
Fulgent Genetics, Inc. Common Stock (FLGT) Q2 2020 Earnings Call Transcript
10:01am, Wednesday, 05'th Aug 2020
On the call today is Ming Hsieh, chief executive officer; Paul Kim, chief financial officer; and Brandon Perthuis, chief commercial officer. The company's press release discussing its financial resul
The Daily Biotech Pulse: Novavax Vaccine Data, Aerpio Gets $5.1M Funding For COVID Trial, Rigel Gains Big On Earnings
12:00am, Wednesday, 05'th Aug 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 4)
ABIOMED, Inc. (NASDAQ: ABMD) (FDA approved the emergency use of Abiomed's Impella heart pump in combination...
Fulgent Genetics Reports Record Second Quarter 2020 Financial Results | MarketScreener
08:06pm, Tuesday, 04'th Aug 2020Fulgent Genetics Reports Record Second Quarter 2020 Financial Results
08:05pm, Tuesday, 04'th Aug 2020
Second Quarter 2020 Results: * Record Revenue of $17.3 million, growing 105% year-over-year * Record Billable tests delivered total 180,513, growing 1003% year-over-year * Gross Margin improved a
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 3)
ABIOMED, Inc. (NASDAQ: ABMD)
ALX Oncology Holdings Inc (NASDAQ: ALXO)
Annexon Inc (NASDAQ: ANNX)
Atossa...
Fulgent Genetics (FLGT) Scheduled to Post Quarterly Earnings on Tuesday
02:44am, Sunday, 02'nd Aug 2020
Fulgent Genetics (NASDAQ:FLGT) will issue its quarterly earnings data after the market closes on Tuesday, August 4th. Analysts expect the company to announce earnings of ($0.03) per share for the quar
The Week Ahead In Biotech: Novavax Coronavirus Vaccine Readout, FDA Decisions And More Earnings
12:00am, Sunday, 02'nd Aug 2020
Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical readouts.
COVID-19 news flow continued to pour in,...
The Daily Biotech Pulse: Merck's Breakthrough Therapy Designation, Sonoma Surges On Sanitizer News, Sanofi-Glaxo And More
12:00am, Wednesday, 29'th Jul 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 28)
Axonics Modulation Technologies Inc (NASDAQ: AXNX)
Capricor Therapeutics Inc (NASDAQ: CAPR)
Fulgent Genetics Inc...
